Skip to main content
CROX
NASDAQ Manufacturing

Crocs Posts Record Q2 Revenue of $1.18B, Lifts Full-Year Outlook, and Supercharges Buyback to $2B

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Industrial
Sentiment info
Positive
Importance info
8
Price
$119.7
Mkt Cap
$5.948B
52W Low
$73.205
52W High
$140.42
52W Position info
64% above low
Off High info
15% below high
Rel. Volume info
1.2× avg
Market data snapshot near publication time

CROX sits 64% above its 52-week low of $73.205.

Summary

Crocs posted record Q2 revenue of $1.18B, raised full-year guidance, and expanded its buyback program to $2B — a powerful signal of financial strength after last year's impairment-driven loss.


Key Events · Earnings and Guidance · CROX

  • Record Q2 Revenue

    Revenue reached $1.18 billion, a 2.6% increase year-over-year, driven by Crocs Brand growth of 4.3%.

  • Raised Full-Year Guidance

    Management lifted its full-year revenue and earnings outlook following the strong Q2 performance.

  • $1.5B Buyback Expansion

    The board approved a $1.5 billion increase to the share repurchase authorization, bringing the total available to approximately $2.0 billion.

  • No HEYDUDE Impairment Repeat

    Unlike Q2 2025, which included $738.1 million in HEYDUDE impairment charges, this quarter had no such write-downs, allowing net income of $204.9 million.


Analysis · CROX · Manufacturing

A record second quarter underscores Crocs' momentum: revenue climbed 2.6% year-over-year to $1.18 billion, and management responded by raising its full-year guidance. The contrast with last year's $738 million impairment-driven loss is stark. Adding to the bullish signal, the board authorized a $1.5 billion increase to the share repurchase program, bringing total capacity to roughly $2 billion. That level of buyback firepower, paired with a quarter free of the HEYDUDE impairment charges that sank prior results, reflects deep confidence in the brand turnaround and cash generation. Although the stock slipped 11% premarket on flat Q3 revenue guidance, the dominant story remains the underlying Q2 beat and the aggressive capital return plan.

How filings like this one have moved

In the 30 days to Oct 5, 2026, 36.9% of the 964 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.65%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, CROX was trading at $119.70 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $5.9B. The 52-week trading range was $73.21 to $140.42. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

CROX - Latest Insights

CROX
Jul 30, 2026, 7:11 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $120.00
Real-time Price: $118.09 info
Change: -$1.91 (-2%) info
Market Cap: $5.662B info
CROX
Jul 30, 2026, 7:02 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $118.00
Real-time Price: $118.09 info
Change: +$0.090 (+0.08%) info
Market Cap: $5.662B info
CROX
Jun 10, 2026, 12:51 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $123.23
Real-time Price: $118.09 info
Change: -$5.14 (-4%) info
Market Cap: $5.662B info
CROX
Jun 05, 2026, 4:26 PM EDT
Filing Type: 144
Importance Score:
7
Price at Filing: $116.97
Real-time Price: $118.09 info
Change: +$1.12 (+0.96%) info
Market Cap: $5.662B info
CROX
Apr 30, 2026, 2:32 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $102.00
Real-time Price: $118.09 info
Change: +$16.09 (+16%) info
Market Cap: $5.662B info